JUNG; Myung Eun

Patent Applications and Registrations

Patent applications and USPTO patent grants for JUNG; Myung Eun.The latest application filed is for "factor viii or factor ix gene knockout rabbit, method for preparing same and use thereof".

Company Profile

2.15.17

JUNG; Myung Eun - Gyeonggi-do KR
JUNG; Myung-Eun - Yongin-si KR
Jung; Myung Eun - Yongin KR
Jung; Myung Eun - Seongnam-si KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Factor Viii Or Factor Ix Gene Knockout Rabbit, Method For Preparing Same And Use Thereof App 20210161111 - KIM; So Ra ; et al.	2021-06-03
Hunter Syndrome Therapeutic Agent And Treatment Method App 20200093899 - LEE; Jin-Kyung ; et al.	2020-03-26
Hunter syndrome therapeutic agent and treatment method Grant 10,561,713 - Lee , et al. Feb	2020-02-18
Hunter Syndrome Therapeutic Agent And Treatment Method App 20180303914 - LEE; Jin-Kyung ; et al.	2018-10-25
Fused ring heteroaryl compounds and their use as Trk inhibitors Grant 9,701,681 - Kim , et al. July 11, 2	2017-07-11
Diphenylmethane derivatives as SGLT2 inhibitors Grant 9,371,303 - Choi , et al. June 21, 2	2016-06-21
Fused Ring Heteroaryl Compounds And Their Use As Trk Inhibitors App 20160168156 - Kim; Moonsoo ; et al.	2016-06-16
Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives Grant 9,340,521 - Choi , et al. May 17, 2	2016-05-17
Novel Diphenylmethane Derivatives As Sglt2 Inhibitors App 20150152075 - CHOI; Soongyu ; et al.	2015-06-04
Diphenylmethane derivatives as SGLT2 inhibitors Grant 9,034,921 - Choi , et al. May 19, 2	2015-05-19
Method For Dual Inhibition Of Sglt1 And Sglt2 Using Diphenylmethane Derivatives App 20140274918 - CHOI; Soongyu ; et al.	2014-09-18
Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same Grant 8,835,436 - Lee , et al. September 16, 2	2014-09-16
Arylpiperazine-containing purine derivatives and uses thereof Grant 8,785,453 - Lee , et al. July 22, 2	2014-07-22
Novel Diphenylmethane Derivatives As Sglt2 Inhibitors App 20140088079 - Choi; Soongyu ; et al.	2014-03-27
C-aryl glucoside SGLT2 inhibitors and pharmaceutical compositions comprising same Grant 8,541,380 - Lee , et al. September 24, 2	2013-09-24
Sulfur containing pyrazole-heterocycle derivatives as cannabinoid CB1 receptor antagonists Grant 8,309,584 - Lee , et al. November 13, 2	2012-11-13
Arylpiperazine-containing Purine Derivatives And Uses Thereof App 20120232090 - Lee; Jinhwa ; et al.	2012-09-13
Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for Parkinson'S disease prevention or treatment Grant 8,178,551 - Lee , et al. May 15, 2	2012-05-15
Novel Arylpiperazine-containing Imidazole 4-carboxamide Derivatives And Pharmaceutical Composition Comprising Same App 20120115881 - Lee; Jinhwa ; et al.	2012-05-10
Novel C-aryl Glucoside Sglt2 Inhibitors And Pharmaceutical Compositions Comprising Same App 20120101051 - Lee; Jinhwa ; et al.	2012-04-26
Sulfur Containing Pyrazole-heterocycle Derivatives As Cannabinoid Cb1 Receptor Antagonists App 20110178140 - Lee; Jinhwa ; et al.	2011-07-21
Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists Grant 7,875,647 - Lee , et al. January 25, 2	2011-01-25
Orally Bioavailable Products Of (+)-3-hydroxymorphinan For Parkinson's Disease Prevention Or Treatment App 20100113500 - Lee; Jinhwa ; et al.	2010-05-06
Azole Derivatives as Cannabinoid CB1 Receptor Antagonists App 20080262066 - LEE; Jinhwa ; et al.	2008-10-23
Heteroaryl-Imidazole Derivatives as Cannabinoid CB1 Receptor Antagonists App 20080207705 - LEE; Jinhwa ; et al.	2008-08-28
Heteroaryl-imidazole Derivatives As Cannabinoid Cb1 Receptor Antagonists App 20080207704 - Lee; Jinhwa ; et al.	2008-08-28
Heteroaryl-Pyrazole Derivatives as Cannabinoid CB1 Receptor Antagonists App 20080081812 - LEE; Jinhwa ; et al.	2008-04-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.